In this episode, we delve into the emerging trend of 'headless' software, as KPMG and OpenAI pioneer a future where work is driven by conversation rather than clicks. We also explore the burgeoning landscape of AI in drug discovery, where investors are pouring resources into potential breakthroughs, despite the current gap in approvals. Join us as we navigate these transformative shifts reshaping technology and innovation.